Immunological parameters as a new lead in the diagnosis of ovarian cancer

被引：0

作者：

Baert, T. ^{[1
,2
]}

Timmerman, D. ^{[1
,3
]}

Vergote, I. ^{[1
,2
]}

Coosemans, A. ^{[1
,2
]}

机构：

[1] UZ Leuven, Gynaecol & Obstet, B-3000 Leuven, Belgium

[2] Katholieke Univ Leuven, Dept Oncol, Leuven Canc Inst, B-3000 Leuven, Belgium

[3] Katholieke Univ Leuven, Dept Dev & Regenerat, B-3000 Leuven, Belgium

来源：

FACTS VIEWS AND VISION IN OBGYN | 2015年 / 7卷 / 01期

基金：

比利时弗兰德研究基金会;

关键词：

Ovarian cancer; diagnosis; prognostic marker; immunosuppression; regulatory T cell; myeloid derived suppressor cells; tumor-associated macrophages;

D O I：

暂无

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

Ovarian cancer is the leading cause of pelvic gynecological cancer death in Europe. Prognosis is poor in women diagnosed at stage III to IV or in case disease recurs. Platin-based chemotherapy and radical surgery have already improved prognosis significantly. Novel strategies in the treatment of ovarian cancer are being searched for. The study of the immune system as a valuable parameter in the development of ovarian cancer has been neglected for a long time. Nevertheless, this is a field in full progression and might open new perspectives in the diagnosis and prognosis of ovarian cancer patients and could lead to a more motivated choice of targeted therapies.

引用

页码：67 / 72

页数：6

共 50 条

[1] OVERVIEW ON NEW IMMUNOLOGICAL MARKERS FOR DIAGNOSIS OF CANCER
HERBERMAN, RB
CANCER, 1978, 42 (03) : 1595 - 1600
[2] IMMUNOLOGICAL PARAMETERS IN THE DIAGNOSIS OF ALLERGIES
KLEINETEBBE, J
HEROLD, D
KUNKEL, G
ARZTLICHE LABORATORIUM, 1988, 34 (11): : 321 - 327
[3] Immunological treatment of ovarian cancer
Cannon, MJ
Santin, AD
O'Brien, TJ
CURRENT OPINION IN OBSTETRICS & GYNECOLOGY, 2004, 16 (01) : 87 - 92
[4] IMMUNOLOGICAL DIAGNOSIS OF CANCER
FEINERMAN, B
ANNALS OF ALLERGY, 1979, 43 (01): : 24 - 25
[5] IMMUNOLOGICAL DIAGNOSIS OF CANCER
SHUSTER, J
EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1984, 20 (12): : 1459 - 1462
[6] IMMUNOLOGICAL DIAGNOSIS OF CANCER
SCHMOLKE, B
ZEITSCHRIFT FUR LYMPHOLOGIE-JOURNAL OF LYMPHOLOGY, 1990, 14 (02): : 58 - 61
[7] NEW FRONTIERS IN OVARIAN-CANCER DIAGNOSIS AND MANAGEMENT
BARBER, HRK
YALE JOURNAL OF BIOLOGY AND MEDICINE, 1991, 64 (02): : 127 - 141
[8] IMMUNOLOGICAL CONTROL OF OVARIAN-CANCER
ZIGHELBOIM, J
NIO, Y
BEREK, JS
BONAVIDA, B
NATURAL IMMUNITY AND CELL GROWTH REGULATION, 1988, 7 (04) : 216 - 225
[9] Discussion: Immunological therapeutics in ovarian cancer
Balkwill, F
Schlom, J
Berek, J
Epenetos, A
Bookman, M
Freedman, R
Wilbanks, G
GYNECOLOGIC ONCOLOGY, 2003, 88 (01) : S110 - S113
[10] Preliminary application of multiple parameters spectral CT in the diagnosis of ovarian cancer
Pang, Tao
Liu, Zhao-di
Deng, Kai
Zhang, Cheng-qi
Wang, Guang-li
MEDICINE, 2017, 96 (32)

← 1 2 3 4 5 →